Navigation Links
SUTIMCo International Inc. to Attend 125th AOAC Annual Meeting

SANTA ANA, Calif., Sept. 12, 2011 /PRNewswire/ -- SUTIMCo International, Inc. (Pink Sheets: SUTI) is pleased to announce that it will send a corporate executive to the 125th Annual Meeting of The Association of Analytical Communities (AOAC) being held September 18-21 in New Orleans.   For over a century, AOAC has developed method validation programs for medical devices as well as proficiency testing and accreditation programs for laboratories.  The meeting is an international showcase for medical devices, attracting manufacturers and the customers who use their products in the lab, the plant and in the field.

SUTIMCo Vice President of Business Development Ed Ellsworth will attend the AOAC meeting to discuss the latest developments at CapWave Sensors, Inc. to produce Searchlight™ - a portable medical device initially serving the food safety testing market.  CapWave will make announcements soon regarding new strategic partnerships for product development that will accelerate time to market and contribute innovative technology to Searchlight.

AOAC is a global organization of 3,000 members whose scientific interests are in the agricultural, food, drug, and environmental science communities.  The annual meeting attracts some of the top firms in the industry including: Agilent Technologies, Thermo Scientific, Romer Labs, Biotage, Fisher Scientific and bioMerieux.

"Our presence at AOAC gives CapWave the opportunity to meet with prospective customers and introduce them to the Searchlight technology," stated Ed Ellsworth, Vice President of Business Development for SUTIMCo International, Inc.  "These are the experts in the labs.  I'm eager to get their input on our technology, learn precisely what they need and apply that to our product."

CapWave's Searchlight™ testing device is a rapid, sensitive, and portable amino chemistry platform based on the Enzyme-Linked Immuno-Sorbent Assay (ELISA) biochemical technique.  For food safety testing, Searchlight is capable of detecting toxins including E. coli, salmonella, listeria and campylobacter.  According to the Centers for Disease Control and Prevention (CDC), about 48 million people (1 in 6 Americans) get sick, 128,000 are hospitalized, and 3,000 die each year from foodborne diseases.

"As we bring strategic partners on board, both CapWave and the Searchlight device come into greater focus," Ellsworth said.  "As I share our story at AOAC, I believe the industry will be intrigued by this device.  More sensitivity, more speed, smaller sample sizes, it's an elegant solution."

The Searchlight™ device will first be available for food safety testing.  Product development for the veterinary and in vitro diagnostic markets is also being evaluated.

To set up a meeting with SUTIMCo at AOAC, please contact Boost Marketing at (407) 389-5900

For more information on CapWave Sensors, please visit;

For more information on SUTIMCo, its portfolio companies, and university partners, please visit;

About SUTIMCo International, Inc.:

SUTIMCo International Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. SUTIMCo International through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, SUTIMCo can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.

SUTIMCo International, Inc.
Investor Relations

SOURCE SUTIMCo International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New International Pharmaceutical Company Pro Bono Bio Launched Today
2. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
3. VWR International, LLC Acquires INTERNATIONAL P.B.I. S.p.A.
4. Bench International Expands Presence in Europe with Opening of Offices in Switzerland
5. Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011
6. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
7. Chindex International, Inc. Announces Participation in Upcoming Investor Conferences
8. Pharmaceutics International, Inc. (Pii) Successfully Completes EMA and FDA Inspection
9. Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society
10. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
11. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
(Date:11/25/2015)... issue of United States patent No. 9,192,509  entitled: " Methods and Apparatus ... AVACEN 100 dry heat therapy medical device and specific methods of use, referred to by the ... - ... ... ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... November 25, 2015 --> ... sie eine Lizenz für das Patent über eine neue ... und ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... ins Leben gerufenen und von Edelris gemeinsam mit seinen ... ein Behandlungsziel für HBV identifiziert, und es wurden neue ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... "When ... that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In ... She developed the patent-pending RECOVERY BRA for added comfort and support. The bra ...
(Date:11/25/2015)... ... November 25, 2015 , ... Many people know of ... weight gain, cold hands, and dry skin. But many people who find their cholesterol ... exercise regimen instead of their thyroid, especially if they don’t have any of the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to be thankful ... Create Real Impact awards. California Casualty is proud to support the contest ... distracted and reckless driving, the number one killer of young drivers. , Almost ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. Seidel, DMD and ... of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses ... a dentist in Gettysburg, PA . From routine visits to cosmetic treatments, ...
(Date:11/24/2015)... ... November 24, 2015 , ... Young patients with a wide variety of ... and Dr. Kedar S. Lele, who are pediatric dentists in Tucson, AZ . ... WaterLase iPlus 2.0™ system causes minimal discomfort and bleeding to the patient during treatment ...
Breaking Medicine News(10 mins):